Legend Biotech (LEGN) Revenue (QoQ) (2019 - 2025)
Legend Biotech (LEGN) Revenue (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.47% |
| Sep 30, 2025 | 6.77% |
| Jun 30, 2025 | 30.76% |
| Mar 31, 2025 | 4.59% |
| Dec 31, 2024 | 16.41% |
| Sep 30, 2024 | -14.11% |
| Jun 30, 2024 | 98.45% |
| Mar 31, 2024 | -99.88% |
| Dec 31, 2023 | 82,663.79% |
| Sep 30, 2023 | 30.93% |
| Jun 30, 2023 | 101.81% |
| Mar 31, 2023 | 31.49% |
| Dec 31, 2022 | 0.99% |
| Sep 30, 2022 | 128.56% |
| Jun 30, 2022 | -76.08% |
| Mar 31, 2022 | 28.32% |
| Dec 31, 2021 | 130.99% |
| Sep 30, 2021 | -16.56% |
| Jun 30, 2021 | 47.88% |
| Mar 31, 2021 | -66.45% |